AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) Accounts Payable

Annual Accounts Payable:

$5.19M+$860.00K(+19.88%)
December 31, 2024

Summary

  • As of today, AUPH annual accounts payable is $5.19 million, with the most recent change of +$860.00 thousand (+19.88%) on December 31, 2024.
  • During the last 3 years, AUPH annual accounts payable has risen by +$1.31 million (+33.72%).
  • AUPH annual accounts payable is now -47.24% below its all-time high of $9.83 million, reached on December 31, 2007.

Performance

AUPH Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

Quarterly Accounts Payable:

$2.21M-$1.10M(-33.15%)
September 30, 2025

Summary

  • As of today, AUPH quarterly accounts payable is $2.21 million, with the most recent change of -$1.10 million (-33.15%) on September 30, 2025.
  • Over the past year, AUPH quarterly accounts payable has dropped by -$6.66 million (-75.06%).
  • AUPH quarterly accounts payable is now -89.03% below its all-time high of $20.19 million, reached on September 30, 2020.

Performance

AUPH Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AUPH Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+19.9%-75.1%
3Y3 Years+33.7%+100.0%
5Y5 Years+24.9%-89.0%

AUPH Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+68.0%-75.1%>+9999.0%
5Y5-Yearat high+96.8%-89.0%>+9999.0%
All-TimeAll-Time-47.2%+1275.5%-89.0%>+9999.0%

AUPH Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$2.21M(-33.2%)
Jun 2025
-
$3.31M(-21.5%)
Mar 2025
-
$4.22M(-18.6%)
Dec 2024
$5.19M(+19.9%)
$5.19M(-41.6%)
Sep 2024
-
$8.88M(+5.5%)
Jun 2024
-
$8.41M(+48.4%)
Mar 2024
-
$5.67M(+31.1%)
Dec 2023
$4.33M(+40.2%)
$4.33M(-51.1%)
Sep 2023
-
$8.85M(+84.2%)
Jun 2023
-
$4.81M(+30.7%)
Mar 2023
-
$3.68M(+19.2%)
Dec 2022
$3.09M(-20.4%)
$3.09M(>+9900.0%)
Sep 2022
-
$0.00(0.0%)
Jun 2022
-
$0.00(-100.0%)
Mar 2022
-
$3.27M(-15.8%)
Dec 2021
$3.88M(+47.2%)
$3.88M(+18.9%)
Sep 2021
-
$3.26M(+28.7%)
Jun 2021
-
$2.54M(+16.2%)
Mar 2021
-
$2.18M(-17.2%)
Dec 2020
$2.63M(-36.6%)
$2.63M(-86.9%)
Sep 2020
-
$20.19M(+48.0%)
Jun 2020
-
$13.64M(+9.9%)
Mar 2020
-
$12.41M(+11.0%)
Dec 2019
$4.15M(+40.7%)
$11.18M(-15.8%)
Sep 2019
-
$13.27M(+89.9%)
Jun 2019
-
$6.99M(+12.7%)
Mar 2019
-
$6.20M(-12.3%)
Dec 2018
$2.95M(-21.8%)
$7.07M(+5.6%)
Sep 2018
-
$6.69M(+37.0%)
Jun 2018
-
$4.89M(-4.6%)
Mar 2018
-
$5.12M(-35.7%)
Dec 2017
$3.77M(+31.8%)
$7.96M(+19.4%)
Sep 2017
-
$6.67M(+93.8%)
Jun 2017
-
$3.44M(-43.9%)
Mar 2017
-
$6.13M(+5.9%)
Dec 2016
$2.86M(+37.7%)
$5.79M(+97.5%)
Sep 2016
-
$2.93M(+19.1%)
Jun 2016
-
$2.46M(+14.6%)
Mar 2016
-
$2.15M(+3.4%)
Dec 2015
$2.08M(+49.4%)
$2.08M(-42.5%)
Sep 2015
-
$3.62M(+7.9%)
Jun 2015
-
$3.35M(+65.5%)
Mar 2015
-
$2.02M(+45.5%)
Dec 2014
$1.39M(+26.0%)
$1.39M(-39.0%)
Sep 2014
-
$2.28M(-13.6%)
Jun 2014
-
$2.64M(+84.1%)
Mar 2014
-
$1.44M(+30.0%)
Dec 2013
$1.10M(-5.1%)
$1.10M(+2.7%)
Sep 2013
-
$1.08M(-57.0%)
Jun 2013
-
$2.50M(+20.8%)
Mar 2013
-
$2.07M(+78.1%)
DateAnnualQuarterly
Dec 2012
$1.16M(+208.7%)
$1.16M(-60.6%)
Sep 2012
-
$2.96M(+202.8%)
Jun 2012
-
$976.00K(+18.2%)
Mar 2012
-
$825.50K(+118.9%)
Dec 2011
$377.10K(-56.1%)
$377.10K(-21.9%)
Sep 2011
-
$482.70K(-49.3%)
Jun 2011
-
$951.20K(+46.2%)
Mar 2011
-
$650.70K(-24.2%)
Dec 2010
$858.50K(-57.9%)
$858.50K(-15.7%)
Sep 2010
-
$1.02M(+7.1%)
Jun 2010
-
$951.40K(-34.0%)
Mar 2010
-
$1.44M(-29.4%)
Dec 2009
$2.04M(-36.7%)
$2.04M(+21.2%)
Sep 2009
-
$1.68M(+129.5%)
Jun 2009
-
$733.60K(-76.3%)
Mar 2009
-
$3.09M(-4.1%)
Dec 2008
$3.23M(-67.2%)
$3.23M(-9.6%)
Sep 2008
-
$3.57M(-24.2%)
Jun 2008
-
$4.71M(+18.3%)
Mar 2008
-
$3.98M(-59.5%)
Dec 2007
$9.83M(+199.9%)
$9.83M(+56.4%)
Sep 2007
-
$6.29M(-17.0%)
Jun 2007
-
$7.58M(+53.6%)
Mar 2007
-
$4.93M(+50.7%)
Dec 2006
$3.28M(+42.4%)
$3.27M(-21.5%)
Sep 2006
-
$4.17M(+36.1%)
Jun 2006
-
$3.06M(-28.7%)
Mar 2006
-
$4.30M(-11.6%)
Dec 2005
$2.30M(-16.4%)
$4.86M(+48.1%)
Sep 2005
-
$3.28M(+26.3%)
Jun 2005
-
$2.60M(+7.7%)
Mar 2005
-
$2.41M(-36.2%)
Dec 2004
$2.75M(+208.1%)
$3.79M(+12.3%)
Sep 2004
-
$3.37M(+31.6%)
Jun 2004
-
$2.56M(-47.4%)
Mar 2004
-
$4.87M(-4.6%)
Dec 2003
$893.80K(-68.6%)
$5.10M(+43.6%)
Sep 2003
-
$3.55M(+9.4%)
Jun 2003
-
$3.25M(+18.1%)
Mar 2003
-
$2.75M(+23.8%)
Dec 2002
$2.85M(+73.1%)
$2.22M(-21.9%)
Sep 2002
-
$2.84M(-26.9%)
Jun 2002
-
$3.89M(+144.1%)
Mar 2002
-
$1.59M(+113.4%)
Dec 2001
$1.65M(+46.0%)
-
Dec 2000
$1.13M(+49.9%)
-
Nov 1999
$752.20K(-34.3%)
$747.00K(+1.5%)
Aug 1999
-
$736.00K(-9.6%)
May 1999
-
$813.80K(-18.2%)
Feb 1999
-
$994.40K
Nov 1998
$1.15M
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual accounts payable year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly accounts payable year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual accounts payable?

The current annual accounts payable of AUPH is $5.19M

What is the all-time high annual accounts payable for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual accounts payable is $9.83M

What is Aurinia Pharmaceuticals Inc. annual accounts payable year-on-year change?

Over the past year, AUPH annual accounts payable has changed by +$860.00K (+19.88%)

What is Aurinia Pharmaceuticals Inc. quarterly accounts payable?

The current quarterly accounts payable of AUPH is $2.21M

What is the all-time high quarterly accounts payable for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly accounts payable is $20.19M

What is Aurinia Pharmaceuticals Inc. quarterly accounts payable year-on-year change?

Over the past year, AUPH quarterly accounts payable has changed by -$6.66M (-75.06%)
On this page